BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 2, 2003
View Archived Issues
CHF-3381, a potential new therapy for peripheral painful neuropathies
Read More
Squalene synthase inhibitor TAK-475 may have therapeutic potential in dyslipidemia
Read More
RWJ-58643, a tryptase inhibitor with potential antiasthmatic activity
Read More
JIMB-01, a microtubule-modifying agent, has antiproliferative properties in human malignant tumors
Read More
PSA-activated thapsigargin prodrug as a specific agent for prostate cancer
Read More
Adenosine A2A receptor antagonist benefits patients with Parkinson's disease
Read More
Fluconazole effective in treating early septic shock
Read More
Melagatran combined with ximelagatran may be effective in preventing postoperative thromboembolism
Read More
New MEK inhibitors and their use patented
Read More
GSK scientists present novel 5-HT6 ligands for psychosis, depression, anxiety, etc.
Read More
New beta4-selective acetylcholine receptor modulators under study at Lilly
Read More
Pyrimidine-based NS5B inhibitors newly discovered by Italian team
Read More
New HIV integrase inhibitors in early development at Merck
Read More
Novel erythromycin antibiotics designed by Kosan scientists
Read More
Daiichi discontinues development of DE-310
Read More
New warnings added to Zenapax labeling
Read More
Alert issued on Reyataz in combination with Viread
Read More
MacroChem expands phase II Topiglan trial into U.S.
Read More
FDA grants orphan drug designation for Fidelin
Read More
Highlights in psychogeriatrics
Read More
New phase I/II trial to evaluate Xcellerated T Cells in treatment of CLL
Read More
Once-daily Cipro XR approved for treatment of cUTIs
Read More
Nabi submits supplemental data for Nabi-HB Intravenous BLA
Read More
Wellbutrin XL approved for major depressive disorder
Read More